# Healthcare News Digest - 2025-12-29

**31 articles** from 5 sources

---

## BioPharma Dive

### [Novo Nordiskâ€™s weight loss pill approved by FDA](https://www.biopharmadive.com/news/novo-nordisk-oral-wegovy-fda-approve-glp-1/808578/)

Title: Novo Nordiskâ€™s weight loss pill approved by FDA

URL Source: https://www.biopharmadive.com/news/novo-nordisk-oral-wegovy-fda-approve-glp-1/808578/

Published Time: 2025-12-23T11:16:00

Markdown Content:
Novo Nordiskâ€™s weight loss pill approved by FDA | BioPharma Dive
===============

Opens in a new window Opens an external website Opens an external website in a new window

This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. To learn more, view the following link: [Privacy Policy](https://www.techtarget.com/privacy-policy/)

[Skip to main content](https://www.biopharmadive.com/news/novo-nordisk-oral-wegovy-fda-approve-glp-1/808578/#skip-link-target)

![Image 4: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)

 CONTINUE TO SITE âžž 

Donâ€™t miss tomorrowâ€™s biopharma industry news
=============================================

Let BioPharma Diveâ€™s free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Commercialization Weekly Every Wednesday 

- [x]  Gene Therapy Weekly Every Thursday 

- [x]  Emerging Biotech Weekly Every Tuesday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 5: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)](https://www.biopharmadive.com/)

*   [Deep Dive](https://www.biopharmadive.com/deep-dive/)
*   [Library](https://www.biopharmadive.com/library/)
*   [Events](https://www.biopharmadive.com/events/)
*   [Press Releases](https://www.biopharmadive.com/press-release/)
*    Topics 

[Sign up](https://www.biopharmadive.com/signup/?signup_location=header&signup_path=/news/novo-nordisk-oral-wegovy-fda-approve-glp-1/808578/

*[Truncated...]*

---

### [Biopharma CEO optimism is wavering in the US](https://www.biopharmadive.com/news/biopharma-ceo-optimism-us-drug-pharma-ai/808546/)

Title: Biopharma CEO optimism is wavering in the US

URL Source: https://www.biopharmadive.com/news/biopharma-ceo-optimism-us-drug-pharma-ai/808546/

Published Time: 2025-12-23T06:00:00

Markdown Content:
Biopharma CEO optimism is wavering in the US | BioPharma Dive
===============

Opens in a new window Opens an external website Opens an external website in a new window

This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. To learn more, view the following link: [Privacy Policy](https://www.techtarget.com/privacy-policy/)

[Skip to main content](https://www.biopharmadive.com/news/biopharma-ceo-optimism-us-drug-pharma-ai/808546/#skip-link-target)

![Image 1: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)

 CONTINUE TO SITE âžž 

Donâ€™t miss tomorrowâ€™s biopharma industry news
=============================================

Let BioPharma Diveâ€™s free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Commercialization Weekly Every Wednesday 

- [x]  Gene Therapy Weekly Every Thursday 

- [x]  Emerging Biotech Weekly Every Tuesday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 2: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)](https://www.biopharmadive.com/)

*   [Deep Dive](https://www.biopharmadive.com/deep-dive/)
*   [Library](https://www.biopharmadive.com/library/)
*   [Events](https://www.biopharmadive.com/events/)
*   [Press Releases](https://www.biopharmadive.com/press-release/)
*    Topics 

[Sign up](https://www.biopharmadive.com/signup/?signup_location=header&signup_path=/news/biopharma-ceo-optimism-us-drug-pharma-ai/808546/)![Image 3: 

*[Truncated...]*

---

### [Biopharma climbs higher as 9 drugmakers ink â€˜panderingâ€™ drug price deals with Trump](https://www.biopharmadive.com/news/trump-most-favored-nation-drug-price-deals/808466/)

Title: Biopharma climbs higher as 9 drugmakers ink â€˜panderingâ€™ drug price deals with Trump

URL Source: https://www.biopharmadive.com/news/trump-most-favored-nation-drug-price-deals/808466/

Published Time: 2025-12-22T10:47:00

Markdown Content:
Biopharma climbs higher as 9 drugmakers ink â€˜panderingâ€™ drug price deals with Trump | BioPharma Dive
===============

Opens in a new window Opens an external website Opens an external website in a new window

This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. To learn more, view the following link: [Privacy Policy](https://www.techtarget.com/privacy-policy/)

[Skip to main content](https://www.biopharmadive.com/news/trump-most-favored-nation-drug-price-deals/808466/#skip-link-target)

![Image 3: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)

 CONTINUE TO SITE âžž 

Donâ€™t miss tomorrowâ€™s biopharma industry news
=============================================

Let BioPharma Diveâ€™s free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Commercialization Weekly Every Wednesday 

- [x]  Gene Therapy Weekly Every Thursday 

- [x]  Emerging Biotech Weekly Every Tuesday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 4: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)](https://www.biopharmadive.com/)

*   [Deep Dive](https://www.biopharmadive.com/deep-dive/)
*   [Library](https://www.biopharmadive.com/library/)
*   [Events](https://www.biopharmadive.com/events/)
*   [Press Releases](https://www.biopharmadive.com/press-release/)
*    Topics 

[Sign up](https://www.biopharmadive.com/signup/?signup_location=hea

*[Truncated...]*

---

### [Trump to test â€˜most favored nationâ€™ pricing for Medicare; Shionogi pays $2.5B for ALS drug](https://www.biopharmadive.com/news/trump-medicare-prices-shionogi-crispr-astrazeneca-neurocrine/808467/)

Title: Trump to test â€˜most favored nationâ€™ pricing for Medicare; Shionogi pays $2.5B for ALS drug

URL Source: https://www.biopharmadive.com/news/trump-medicare-prices-shionogi-crispr-astrazeneca-neurocrine/808467/

Published Time: 2025-12-22T10:18:00

Markdown Content:
Trump to test â€˜most favored nationâ€™ pricing for Medicare; Shionogi pays $2.5B for ALS drug | BioPharma Dive
===============

Opens in a new window Opens an external website Opens an external website in a new window

This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. To learn more, view the following link: [Privacy Policy](https://www.techtarget.com/privacy-policy/)

[Skip to main content](https://www.biopharmadive.com/news/trump-medicare-prices-shionogi-crispr-astrazeneca-neurocrine/808467/#skip-link-target)

![Image 3: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)

 CONTINUE TO SITE âžž 

Donâ€™t miss tomorrowâ€™s biopharma industry news
=============================================

Let BioPharma Diveâ€™s free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Commercialization Weekly Every Wednesday 

- [x]  Gene Therapy Weekly Every Thursday 

- [x]  Emerging Biotech Weekly Every Tuesday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 4: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)](https://www.biopharmadive.com/)

*   [Deep Dive](https://www.biopharmadive.com/deep-dive/)
*   [Library](https://www.biopharmadive.com/library/)
*   [Events](https://www.biopharmadive.com/events/)
*   [Press Releases](https://www.biopharmadive.com/press-release/)
*    Topics 

[Sign up](https:/

*[Truncated...]*

---

### [Radiopharmaceutical specialist Aktis seeks an IPO](https://www.biopharmadive.com/news/aktis-oncology-biotech-ipo-radiopharmaceuticals-nectin-4/808472/)

Title: Radiopharmaceutical specialist Aktis seeks an IPO

URL Source: https://www.biopharmadive.com/news/aktis-oncology-biotech-ipo-radiopharmaceuticals-nectin-4/808472/

Published Time: 2025-12-22T08:56:00

Markdown Content:
Radiopharmaceutical specialist Aktis seeks an IPO | BioPharma Dive
===============

Opens in a new window Opens an external website Opens an external website in a new window

This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. To learn more, view the following link: [Privacy Policy](https://www.techtarget.com/privacy-policy/)

[Skip to main content](https://www.biopharmadive.com/news/aktis-oncology-biotech-ipo-radiopharmaceuticals-nectin-4/808472/#skip-link-target)

![Image 1: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)

 CONTINUE TO SITE âžž 

Donâ€™t miss tomorrowâ€™s biopharma industry news
=============================================

Let BioPharma Diveâ€™s free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Commercialization Weekly Every Wednesday 

- [x]  Gene Therapy Weekly Every Thursday 

- [x]  Emerging Biotech Weekly Every Tuesday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 2: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)](https://www.biopharmadive.com/)

*   [Deep Dive](https://www.biopharmadive.com/deep-dive/)
*   [Library](https://www.biopharmadive.com/library/)
*   [Events](https://www.biopharmadive.com/events/)
*   [Press Releases](https://www.biopharmadive.com/press-release/)
*    Topics 

[Sign up](https://www.biopharmadive.com/signup/?signup_location=header&signup_path=/news/aktis-oncology-bio

*[Truncated...]*

---

### [Cytokinetics set to battle Bristol Myers as FDA approves heart drug](https://www.biopharmadive.com/news/cytokinetics-myqorzo-fda-approval-obstructive-hypertrophic-cardiomyopathy-camzyos/808456/)

Title: Cytokinetics set to battle Bristol Myers as FDA approves heart drug

URL Source: https://www.biopharmadive.com/news/cytokinetics-myqorzo-fda-approval-obstructive-hypertrophic-cardiomyopathy-camzyos/808456/

Published Time: 2025-12-21T15:55:00

Markdown Content:
Cytokinetics set to battle Bristol Myers as FDA approves heart drug | BioPharma Dive
===============
[Skip to main content](https://www.biopharmadive.com/news/cytokinetics-myqorzo-fda-approval-obstructive-hypertrophic-cardiomyopathy-camzyos/808456/#skip-link-target)

![Image 1: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)

 CONTINUE TO SITE âžž 

Don't miss tomorrow's biopharma industry news
=============================================

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Commercialization Weekly Every Wednesday 

- [x]  Gene Therapy Weekly Every Thursday 

- [x]  Emerging Biotech Weekly Every Tuesday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 2: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)](https://www.biopharmadive.com/)

*   [Deep Dive](https://www.biopharmadive.com/deep-dive/)
*   [Library](https://www.biopharmadive.com/library/)
*   [Events](https://www.biopharmadive.com/events/)
*   [Press Releases](https://www.biopharmadive.com/press-release/)
*    Topics 

[Sign up](https://www.biopharmadive.com/signup/?signup_location=header)![Image 3: menu](https://www.biopharmadive.com/static/img/menu_icons/menu.svg?273117231121)
*   ![Image 4: search](https://www.biopharmadive.com/static/img/menu_icons/search.svg?320116291121)Search
*   [![Image 5](https://www.biopharmadive.com/static/img/email_icons/mail.svg?273117231121) Sign up](https

*[Truncated...]*

---

### [Patient deaths put Merck, Daiichiâ€™s ADC trial on partial hold](https://www.biopharmadive.com/news/merck-daiichi-sankyo-clinical-hold-ifinatamab-deruxtecan/808385/)

Title: Patient deaths put Merck, Daiichiâ€™s ADC trial on partial hold

URL Source: https://www.biopharmadive.com/news/merck-daiichi-sankyo-clinical-hold-ifinatamab-deruxtecan/808385/

Published Time: 2025-12-19T15:31:00

Markdown Content:
Patient deaths put Merck, Daiichiâ€™s ADC trial on partial hold | BioPharma Dive
===============
[Skip to main content](https://www.biopharmadive.com/news/merck-daiichi-sankyo-clinical-hold-ifinatamab-deruxtecan/808385/#skip-link-target)

![Image 1: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)

 CONTINUE TO SITE âžž 

Don't miss tomorrow's biopharma industry news
=============================================

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Commercialization Weekly Every Wednesday 

- [x]  Gene Therapy Weekly Every Thursday 

- [x]  Emerging Biotech Weekly Every Tuesday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 2: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)](https://www.biopharmadive.com/)

*   [Deep Dive](https://www.biopharmadive.com/deep-dive/)
*   [Library](https://www.biopharmadive.com/library/)
*   [Events](https://www.biopharmadive.com/events/)
*   [Press Releases](https://www.biopharmadive.com/press-release/)
*    Topics 

[Sign up](https://www.biopharmadive.com/signup/?signup_location=header)![Image 3: menu](https://www.biopharmadive.com/static/img/menu_icons/menu.svg?273117231121)
*   ![Image 4: search](https://www.biopharmadive.com/static/img/menu_icons/search.svg?320116291121)Search
*   [![Image 5](https://www.biopharmadive.com/static/img/email_icons/mail.svg?273117231121) Sign up](https://www.biopharmadive.com/signup/?signup_location=header)

Sear

*[Truncated...]*

---

### [BioMarin to buy rare disease drugmaker Amicus for $4.8B](https://www.biopharmadive.com/news/biomarin-amicus-deal-acquisition-rare-disease-drugs/808382/)

Title: BioMarin to buy rare disease drugmaker Amicus for $4.8B

URL Source: https://www.biopharmadive.com/news/biomarin-amicus-deal-acquisition-rare-disease-drugs/808382/

Published Time: 2025-12-19T11:24:00

Markdown Content:
BioMarin to buy rare disease drugmaker Amicus for $4.8B | BioPharma Dive
===============

Opens in a new window Opens an external website Opens an external website in a new window

This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. To learn more, view the following link: [Privacy Policy](https://www.techtarget.com/privacy-policy/)

[Skip to main content](https://www.biopharmadive.com/news/biomarin-amicus-deal-acquisition-rare-disease-drugs/808382/#skip-link-target)

![Image 1: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)

 CONTINUE TO SITE âžž 

Donâ€™t miss tomorrowâ€™s biopharma industry news
=============================================

Let BioPharma Diveâ€™s free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Commercialization Weekly Every Wednesday 

- [x]  Gene Therapy Weekly Every Thursday 

- [x]  Emerging Biotech Weekly Every Tuesday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 2: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)](https://www.biopharmadive.com/)

*   [Deep Dive](https://www.biopharmadive.com/deep-dive/)
*   [Library](https://www.biopharmadive.com/library/)
*   [Events](https://www.biopharmadive.com/events/)
*   [Press Releases](https://www.biopharmadive.com/press-release/)
*    Topics 

[Sign up](https://www.biopharmadive.com/signup/?signup_location=header&signup_path=/news/biomarin-amicus-

*[Truncated...]*

---

### [Novo files for CagriSema approval; Merck and Pfizerâ€™s trial win](https://www.biopharmadive.com/news/novo-cagrisema-merck-pfizer-keytruda-padcev-gsk/808142/)

Title: Novo files for CagriSema approval; Merck and Pfizerâ€™s trial win

URL Source: https://www.biopharmadive.com/news/novo-cagrisema-merck-pfizer-keytruda-padcev-gsk/808142/

Published Time: 2025-12-19T11:01:21

Markdown Content:
Novo files for CagriSema approval; Merck and Pfizerâ€™s trial win | BioPharma Dive
===============

Opens in a new window Opens an external website Opens an external website in a new window

This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. To learn more, view the following link: [Privacy Policy](https://www.techtarget.com/privacy-policy/)

[Skip to main content](https://www.biopharmadive.com/news/novo-cagrisema-merck-pfizer-keytruda-padcev-gsk/808142/#skip-link-target)

![Image 3: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)

 CONTINUE TO SITE âžž 

Donâ€™t miss tomorrowâ€™s biopharma industry news
=============================================

Let BioPharma Diveâ€™s free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Commercialization Weekly Every Wednesday 

- [x]  Gene Therapy Weekly Every Thursday 

- [x]  Emerging Biotech Weekly Every Tuesday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 4: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)](https://www.biopharmadive.com/)

*   [Deep Dive](https://www.biopharmadive.com/deep-dive/)
*   [Library](https://www.biopharmadive.com/library/)
*   [Events](https://www.biopharmadive.com/events/)
*   [Press Releases](https://www.biopharmadive.com/press-release/)
*    Topics 

[Sign up](https://www.biopharmadive.com/signup/?signup_location=header&signup_path=/news/novo-cag

*[Truncated...]*

---

### [Galapagos TYK2 drug hits goal in one trial, misses in another](https://www.biopharmadive.com/news/galapagos-tyk2-drug-GLPG3667-dermatomyositis-lupus-trial/808364/)

Title: Galapagos TYK2 drug hits goal in one trial, misses in another

URL Source: https://www.biopharmadive.com/news/galapagos-tyk2-drug-GLPG3667-dermatomyositis-lupus-trial/808364/

Published Time: 2025-12-19T09:17:04

Markdown Content:
Galapagos TYK2 drug hits goal in one trial, misses in another | BioPharma Dive
===============

Opens in a new window Opens an external website Opens an external website in a new window

This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. To learn more, view the following link: [Privacy Policy](https://www.techtarget.com/privacy-policy/)

[Skip to main content](https://www.biopharmadive.com/news/galapagos-tyk2-drug-GLPG3667-dermatomyositis-lupus-trial/808364/#skip-link-target)

![Image 4: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)

 CONTINUE TO SITE âžž 

Donâ€™t miss tomorrowâ€™s biopharma industry news
=============================================

Let BioPharma Diveâ€™s free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Commercialization Weekly Every Wednesday 

- [x]  Gene Therapy Weekly Every Thursday 

- [x]  Emerging Biotech Weekly Every Tuesday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 5: BioPharma Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/biopharma_black.svg)](https://www.biopharmadive.com/)

*   [Deep Dive](https://www.biopharmadive.com/deep-dive/)
*   [Library](https://www.biopharmadive.com/library/)
*   [Events](https://www.biopharmadive.com/events/)
*   [Press Releases](https://www.biopharmadive.com/press-release/)
*    Topics 

[Sign up](https://www.biopharmadive.com/signup/?signup_location=header&signup_path=

*[Truncated...]*

---

## Healthcare Dive

### [Novo Nordiskâ€™s weight loss pill approved by FDA](https://www.healthcaredive.com/news/novo-nordisk-oral-wegovy-fda-approve-glp-1/808626/)

Title: Novo Nordiskâ€™s weight loss pill approved by FDA

URL Source: https://www.healthcaredive.com/news/novo-nordisk-oral-wegovy-fda-approve-glp-1/808626/

Published Time: 2025-12-23T11:16:00

Markdown Content:
Novo Nordiskâ€™s weight loss pill approved by FDA | Healthcare Dive
===============
[Skip to main content](https://www.healthcaredive.com/news/novo-nordisk-oral-wegovy-fda-approve-glp-1/808626/#skip-link-target)

Don't miss tomorrow's healthcare industry news
==============================================

Let Healthcare Dive's free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Payer Weekly Every Wednesday 

- [x]  IT Weekly Every Thursday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 1: Healthcare Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/healthcare_black.svg)](https://www.healthcaredive.com/)

*   [Deep Dive](https://www.healthcaredive.com/deep-dive/)
*   [Opinion](https://www.healthcaredive.com/opinion/)
*   [Library](https://www.healthcaredive.com/library/)
*   [Events](https://www.healthcaredive.com/events/)
*   [Press Releases](https://www.healthcaredive.com/press-release/)
*    Topics 

[Sign up](https://www.healthcaredive.com/signup/?signup_location=header)![Image 2: menu](https://www.healthcaredive.com/static/img/menu_icons/menu.svg?273117231121)
*   ![Image 3: search](https://www.healthcaredive.com/static/img/menu_icons/search.svg?320116291121)Search
*   [![Image 4](https://www.healthcaredive.com/static/img/email_icons/mail.svg?273117231121) Sign up](https://www.healthcaredive.com/signup/?signup_location=header)

Search ![Image 5: search](https://www.healthcaredive.com/static/img/menu_icons/search.svg?320116291121)![Image 6: close menu](https://www.healthcaredive.com/static/img/menu_icons/clos

*[Truncated...]*

---

### [Trump administration nixes Biden-era health IT policies, including AI â€˜model cardsâ€™](https://www.healthcaredive.com/news/astp-onc-hti5-ai-model-cards-health-it-certification-proposed-rule/808582/)

Title: Trump administration nixes Biden-era health IT policies, including AI â€˜model cardsâ€™

URL Source: https://www.healthcaredive.com/news/astp-onc-hti5-ai-model-cards-health-it-certification-proposed-rule/808582/

Published Time: 2025-12-23T08:54:45

Markdown Content:
Trump administration nixes Biden-era health IT policies, including AI â€˜model cardsâ€™ | Healthcare Dive
===============
[Skip to main content](https://www.healthcaredive.com/news/astp-onc-hti5-ai-model-cards-health-it-certification-proposed-rule/808582/#skip-link-target)

Don't miss tomorrow's healthcare industry news
==============================================

Let Healthcare Dive's free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Payer Weekly Every Wednesday 

- [x]  IT Weekly Every Thursday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 1: Healthcare Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/healthcare_black.svg)](https://www.healthcaredive.com/)

*   [Deep Dive](https://www.healthcaredive.com/deep-dive/)
*   [Opinion](https://www.healthcaredive.com/opinion/)
*   [Library](https://www.healthcaredive.com/library/)
*   [Events](https://www.healthcaredive.com/events/)
*   [Press Releases](https://www.healthcaredive.com/press-release/)
*    Topics 

[Sign up](https://www.healthcaredive.com/signup/?signup_location=header)![Image 2: menu](https://www.healthcaredive.com/static/img/menu_icons/menu.svg?273117231121)
*   ![Image 3: search](https://www.healthcaredive.com/static/img/menu_icons/search.svg?320116291121)Search
*   [![Image 4](https://www.healthcaredive.com/static/img/email_icons/mail.svg?273117231121) Sign up](https://www.healthcaredive.com/signup/?signup_location=header)

Search ![Image 5: search](https://www.healthcaredive.com/static

*[Truncated...]*

---

### [9 more drugmakers ink pricing deals with Trump](https://www.healthcaredive.com/news/trump-most-favored-nation-drug-price-deals/808504/)

Title: 9 more drugmakers ink pricing deals with Trump

URL Source: https://www.healthcaredive.com/news/trump-most-favored-nation-drug-price-deals/808504/

Published Time: 2025-12-22T10:47:00

Markdown Content:
9 more drugmakers ink pricing deals with Trump | Healthcare Dive
===============
[Skip to main content](https://www.healthcaredive.com/news/trump-most-favored-nation-drug-price-deals/808504/#skip-link-target)

Don't miss tomorrow's healthcare industry news
==============================================

Let Healthcare Dive's free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Payer Weekly Every Wednesday 

- [x]  IT Weekly Every Thursday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 1: Healthcare Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/healthcare_black.svg)](https://www.healthcaredive.com/)

*   [Deep Dive](https://www.healthcaredive.com/deep-dive/)
*   [Opinion](https://www.healthcaredive.com/opinion/)
*   [Library](https://www.healthcaredive.com/library/)
*   [Events](https://www.healthcaredive.com/events/)
*   [Press Releases](https://www.healthcaredive.com/press-release/)
*    Topics 

[Sign up](https://www.healthcaredive.com/signup/?signup_location=header)![Image 2: menu](https://www.healthcaredive.com/static/img/menu_icons/menu.svg?273117231121)
*   ![Image 3: search](https://www.healthcaredive.com/static/img/menu_icons/search.svg?320116291121)Search
*   [![Image 4](https://www.healthcaredive.com/static/img/email_icons/mail.svg?273117231121) Sign up](https://www.healthcaredive.com/signup/?signup_location=header)

Search ![Image 5: search](https://www.healthcaredive.com/static/img/menu_icons/search.svg?320116291121)![Image 6: close menu](https://www.healthcaredive.com/static/img/menu_icons/close.

*[Truncated...]*

---

### [HHS seeks input on speeding AI adoption in clinical care](https://www.healthcaredive.com/news/hhs-request-for-information-ai-clinical-care/808489/)

Title: HHS seeks input on speeding AI adoption in clinical care

URL Source: https://www.healthcaredive.com/news/hhs-request-for-information-ai-clinical-care/808489/

Published Time: 2025-12-22T10:06:53

Markdown Content:
HHS seeks input on speeding AI adoption in clinical care | Healthcare Dive
===============
[Skip to main content](https://www.healthcaredive.com/news/hhs-request-for-information-ai-clinical-care/808489/#skip-link-target)

Don't miss tomorrow's healthcare industry news
==============================================

Let Healthcare Dive's free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Payer Weekly Every Wednesday 

- [x]  IT Weekly Every Thursday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 1: Healthcare Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/healthcare_black.svg)](https://www.healthcaredive.com/)

*   [Deep Dive](https://www.healthcaredive.com/deep-dive/)
*   [Opinion](https://www.healthcaredive.com/opinion/)
*   [Library](https://www.healthcaredive.com/library/)
*   [Events](https://www.healthcaredive.com/events/)
*   [Press Releases](https://www.healthcaredive.com/press-release/)
*    Topics 

[Sign up](https://www.healthcaredive.com/signup/?signup_location=header)![Image 2: menu](https://www.healthcaredive.com/static/img/menu_icons/menu.svg?273117231121)
*   ![Image 3: search](https://www.healthcaredive.com/static/img/menu_icons/search.svg?320116291121)Search
*   [![Image 4](https://www.healthcaredive.com/static/img/email_icons/mail.svg?273117231121) Sign up](https://www.healthcaredive.com/signup/?signup_location=header)

Search ![Image 5: search](https://www.healthcaredive.com/static/img/menu_icons/search.svg?320116291121)![Image 6: close menu](https://www.healthcaredive.com/stat

*[Truncated...]*

---

### [UnitedHealth commits to changes after independent review](https://www.healthcaredive.com/news/unitedhealth-independent-review-results-pledges-reform/808474/)

Title: UnitedHealth commits to changes after independent review

URL Source: https://www.healthcaredive.com/news/unitedhealth-independent-review-results-pledges-reform/808474/

Published Time: 2025-12-22T08:57:37

Markdown Content:
UnitedHealth commits to changes after independent review | Healthcare Dive
===============

Opens in a new window Opens an external website Opens an external website in a new window

This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. To learn more, view the following link: [Privacy Policy](https://www.techtarget.com/privacy-policy/)

[Skip to main content](https://www.healthcaredive.com/news/unitedhealth-independent-review-results-pledges-reform/808474/#skip-link-target)

Donâ€™t miss tomorrowâ€™s healthcare industry news
==============================================

Let Healthcare Diveâ€™s free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Payer Weekly Every Wednesday 

- [x]  IT Weekly Every Thursday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 1: Healthcare Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/healthcare_black.svg)](https://www.healthcaredive.com/)

*   [Deep Dive](https://www.healthcaredive.com/deep-dive/)
*   [Opinion](https://www.healthcaredive.com/opinion/)
*   [Library](https://www.healthcaredive.com/library/)
*   [Events](https://www.healthcaredive.com/events/)
*   [Press Releases](https://www.healthcaredive.com/press-release/)
*    Topics 

[Sign up](https://www.healthcaredive.com/signup/?signup_location=header&signup_path=/news/unitedhealth-independent-review-results-pledges-reform/808474/)![Image 2: menu](https://www.healthcaredive.com/static/img/menu_icons/me

*[Truncated...]*

---

### [Trump administration proposes stronger insurer price transparency requirements](https://www.healthcaredive.com/news/trump-administration-strengthens-insurer-price-transparency-requirements/808473/)

Title: Trump administration proposes stronger insurer price transparency requirements

URL Source: https://www.healthcaredive.com/news/trump-administration-strengthens-insurer-price-transparency-requirements/808473/

Published Time: 2025-12-22T08:53:10

Markdown Content:
Trump administration proposes stronger insurer price transparency requirements | Healthcare Dive
===============
[Skip to main content](https://www.healthcaredive.com/news/trump-administration-strengthens-insurer-price-transparency-requirements/808473/#skip-link-target)

Don't miss tomorrow's healthcare industry news
==============================================

Let Healthcare Dive's free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Payer Weekly Every Wednesday 

- [x]  IT Weekly Every Thursday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 1: Healthcare Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/healthcare_black.svg)](https://www.healthcaredive.com/)

*   [Deep Dive](https://www.healthcaredive.com/deep-dive/)
*   [Opinion](https://www.healthcaredive.com/opinion/)
*   [Library](https://www.healthcaredive.com/library/)
*   [Events](https://www.healthcaredive.com/events/)
*   [Press Releases](https://www.healthcaredive.com/press-release/)
*    Topics 

[Sign up](https://www.healthcaredive.com/signup/?signup_location=header)![Image 2: menu](https://www.healthcaredive.com/static/img/menu_icons/menu.svg?273117231121)
*   ![Image 3: search](https://www.healthcaredive.com/static/img/menu_icons/search.svg?320116291121)Search
*   [![Image 4](https://www.healthcaredive.com/static/img/email_icons/mail.svg?273117231121) Sign up](https://www.healthcaredive.com/signup/?signup_location=header)

Search ![Image 5: search](https://www.healthcaredive.com/stat

*[Truncated...]*

---

### [ChristianaCare, Virtua Health end merger talks](https://www.healthcaredive.com/news/christianacare-virtua-health-end-merger-talks/808371/)

Title: ChristianaCare, Virtua Health end merger talks

URL Source: https://www.healthcaredive.com/news/christianacare-virtua-health-end-merger-talks/808371/

Published Time: 2025-12-19T09:52:08

Markdown Content:
ChristianaCare, Virtua Health end merger talks | Healthcare Dive
===============

Opens in a new window Opens an external website Opens an external website in a new window

This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. To learn more, view the following link: [Privacy Policy](https://www.techtarget.com/privacy-policy/)

[Skip to main content](https://www.healthcaredive.com/news/christianacare-virtua-health-end-merger-talks/808371/#skip-link-target)

Donâ€™t miss tomorrowâ€™s healthcare industry news
==============================================

Let Healthcare Diveâ€™s free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Payer Weekly Every Wednesday 

- [x]  IT Weekly Every Thursday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 1: Healthcare Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/healthcare_black.svg)](https://www.healthcaredive.com/)

*   [Deep Dive](https://www.healthcaredive.com/deep-dive/)
*   [Opinion](https://www.healthcaredive.com/opinion/)
*   [Library](https://www.healthcaredive.com/library/)
*   [Events](https://www.healthcaredive.com/events/)
*   [Press Releases](https://www.healthcaredive.com/press-release/)
*    Topics 

[Sign up](https://www.healthcaredive.com/signup/?signup_location=header&signup_path=/news/christianacare-virtua-health-end-merger-talks/808371/)![Image 2: menu](https://www.healthcaredive.com/static/img/menu_icons/menu.svg?273117231121)
*   ![Image 3: search](htt

*[Truncated...]*

---

### [Medicare unveils successor to ACO REACH](https://www.healthcaredive.com/news/aco-lead-medicare-accountable-cms-reach-replacement/808356/)

Title: Medicare unveils successor to ACO REACH

URL Source: https://www.healthcaredive.com/news/aco-lead-medicare-accountable-cms-reach-replacement/808356/

Published Time: 2025-12-19T08:37:56

Markdown Content:
Medicare unveils successor to ACO REACH | Healthcare Dive
===============
[Skip to main content](https://www.healthcaredive.com/news/aco-lead-medicare-accountable-cms-reach-replacement/808356/#skip-link-target)

Don't miss tomorrow's healthcare industry news
==============================================

Let Healthcare Dive's free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Payer Weekly Every Wednesday 

- [x]  IT Weekly Every Thursday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 1: Healthcare Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/healthcare_black.svg)](https://www.healthcaredive.com/)

*   [Deep Dive](https://www.healthcaredive.com/deep-dive/)
*   [Opinion](https://www.healthcaredive.com/opinion/)
*   [Library](https://www.healthcaredive.com/library/)
*   [Events](https://www.healthcaredive.com/events/)
*   [Press Releases](https://www.healthcaredive.com/press-release/)
*    Topics 

[Sign up](https://www.healthcaredive.com/signup/?signup_location=header)![Image 2: menu](https://www.healthcaredive.com/static/img/menu_icons/menu.svg?273117231121)
*   ![Image 3: search](https://www.healthcaredive.com/static/img/menu_icons/search.svg?320116291121)Search
*   [![Image 4](https://www.healthcaredive.com/static/img/email_icons/mail.svg?273117231121) Sign up](https://www.healthcaredive.com/signup/?signup_location=header)

Search ![Image 5: search](https://www.healthcaredive.com/static/img/menu_icons/search.svg?320116291121)![Image 6: close menu](https://www.healthcaredive.com/static/img/menu_icons/cl

*[Truncated...]*

---

### [Trump administration moves to bar hospitals from providing youth gender-affirming care](https://www.healthcaredive.com/news/trump-administration-moves-bar-hospitals-youth-gender-affirming-care/808259/)

Title: Trump administration moves to bar hospitals from providing youth gender-affirming care

URL Source: https://www.healthcaredive.com/news/trump-administration-moves-bar-hospitals-youth-gender-affirming-care/808259/

Published Time: 2025-12-18T16:44:00

Markdown Content:
Trump administration moves to bar hospitals from providing youth gender-affirming care | Healthcare Dive
===============

Opens in a new window Opens an external website Opens an external website in a new window

This website utilizes technologies such as cookies to enable essential site functionality, as well as for analytics, personalization, and targeted advertising. To learn more, view the following link: [Privacy Policy](https://www.techtarget.com/privacy-policy/)

[Skip to main content](https://www.healthcaredive.com/news/trump-administration-moves-bar-hospitals-youth-gender-affirming-care/808259/#skip-link-target)

Donâ€™t miss tomorrowâ€™s healthcare industry news
==============================================

Let Healthcare Diveâ€™s free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Payer Weekly Every Wednesday 

- [x]  IT Weekly Every Thursday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 1: Healthcare Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/healthcare_black.svg)](https://www.healthcaredive.com/)

*   [Deep Dive](https://www.healthcaredive.com/deep-dive/)
*   [Opinion](https://www.healthcaredive.com/opinion/)
*   [Library](https://www.healthcaredive.com/library/)
*   [Events](https://www.healthcaredive.com/events/)
*   [Press Releases](https://www.healthcaredive.com/press-release/)
*    Topics 

[Sign up](https://www.healthcaredive.com/signup/?signup_location=header&signup_path=/news/trump-administration-moves-bar-hospitals-youth-

*[Truncated...]*

---

### [Optum Rx says 100% of network community pharmacies in cost-based contracts](https://www.healthcaredive.com/news/optum-rx-all-community-pharmacies-cost-based/808233/)

Title: Optum Rx says 100% of network community pharmacies in cost-based contracts

URL Source: https://www.healthcaredive.com/news/optum-rx-all-community-pharmacies-cost-based/808233/

Published Time: 2025-12-18T12:19:00

Markdown Content:
Optum Rx says 100% of network community pharmacies in cost-based contracts | Healthcare Dive
===============
[Skip to main content](https://www.healthcaredive.com/news/optum-rx-all-community-pharmacies-cost-based/808233/#skip-link-target)

Don't miss tomorrow's healthcare industry news
==============================================

Let Healthcare Dive's free newsletter keep you informed, straight from your inbox.

- [x]  Daily Dive M-F 

- [x]  Payer Weekly Every Wednesday 

- [x]  IT Weekly Every Thursday 

- [x]  By signing up to receive our newsletter, you agree to our [Terms of Use](https://www.informatechtarget.com/terms-of-use/) and [Privacy Policy](https://www.informatechtarget.com/privacy-policy/). You can unsubscribe at anytime. 

[![Image 1: Healthcare Dive](https://d12v9rtnomnebu.cloudfront.net/logo/publications/healthcare_black.svg)](https://www.healthcaredive.com/)

*   [Deep Dive](https://www.healthcaredive.com/deep-dive/)
*   [Opinion](https://www.healthcaredive.com/opinion/)
*   [Library](https://www.healthcaredive.com/library/)
*   [Events](https://www.healthcaredive.com/events/)
*   [Press Releases](https://www.healthcaredive.com/press-release/)
*    Topics 

[Sign up](https://www.healthcaredive.com/signup/?signup_location=header)![Image 2: menu](https://www.healthcaredive.com/static/img/menu_icons/menu.svg?273117231121)
*   ![Image 3: search](https://www.healthcaredive.com/static/img/menu_icons/search.svg?320116291121)Search
*   [![Image 4](https://www.healthcaredive.com/static/img/email_icons/mail.svg?273117231121) Sign up](https://www.healthcaredive.com/signup/?signup_location=header)

Search ![Image 5: search](https://www.healthcaredive.com/static/img/menu_icons/search.svg?320116291121)![Image 6: close menu]

*[Truncated...]*

---

## Rock Health Weekly

### [Reflections on the year, plus a dose of good cheer](https://mailchi.mp/rockhealth/reflections-on-the-year-plus-a-dose-of-good-cheer?e=1f386dcc61)

---

### [Curve your innovation](https://mailchi.mp/rockhealth/curve-your-innovation?e=1f386dcc61)

---

## Leerink Partners

### [Leerink Partners - Healthtech Week in Review - 12.17.2025.pdf](https://portal.leerink.com/IRPDocumentViewer/Web/DocumentViewerCache.aspx?eDoc=1&docId=72612B6C426A636B6A57396E744F7373302F30396B513D3D&pad=694D574D7466516B6162626B346D617548324E6C6A513D3D&userId=48306C427A7157326978726E586A6A474D79643959773D3D&Email_Id=413750547339344A752B557773484D4464552B4647673D3D&ibUrId=4D657757353465344C7934304C75764B3168663163513D3D)

---

### [https://www.leerink.com/important-disclosures/](https://www.leerink.com/important-disclosures/)

---

### [Leerink Partners - Healthtech Week in Review - 12.10.2025.pdf](https://portal.leerink.com/IRPDocumentViewer/Web/DocumentViewerCache.aspx?eDoc=1&docId=4D30565179433368614476533142456E454D2F4E54673D3D&pad=4754364E4C596B744774354F5030636434326D6E6C513D3D&userId=48306C427A7157326978726E586A6A474D79643959773D3D&Email_Id=6B39757850473734593574584B3949306430454977513D3D&ibUrId=56385878595877466E745044346B6B2B5973755251513D3D)

---

### [https://www.leerink.com/important-disclosures/](https://www.leerink.com/important-disclosures/)

---

## Endpoints News

### [Share your perspective. Endpoints is fielding the next Biopharma Sentiment Index (BPSI), a three-min](https://e.endpointsnews.com/t/t-l-wojdx-jykykhhuld-t/)

Biopharma Sentiment Index (BPSI Q1 2026)
Thank you for taking part in the Biopharma Sentiment Index. This quick survey (4 minutes or less) tracks the mood across the industry â€” science, finance, hiring and regulation. Your input helps shape a quarterly benchmark index that we'll report back to the community.
Note:
Individual responses are confidential; only aggregate results will be reported. Please answer each question to the best of your ability.
Progress
1 of 4
1
Current Conditions
2
Expectations
3
Industry Outlook
4
Demographics (Optional)
Current Conditions
Compared with a year ago, how would you describe overall business conditions in the biopharma industry today?
Better
Same
Worse
Don't know
Would you say that the financial health of your own organization is better off or worse off than it was a year ago?
Better off
Same
Worse off
Don't know / Not applicable
What about the fundraising/financing climate? Would you say it's now easier or more difficult for biopharma companies to raise capital than it was a year ago?
Easier
About the same
More difficult
Don't know
How would you describe the regulatory and policy environment today, compared with a year ago? That includes things like drug approvals, pricing flexibility and government support for research.
More supportive
Unchanged
Less supportive
Don't know
Is hiring at your organization currently expanding or contracting?
Expanding
Flat
Contracting
Don't know / Not applicable
In your own words, how would you describe the current conditions in biopharma?
Next

---

### [The Endpoints winners and losers list: Who was up and who was down in 2025](https://e.endpointsnews.com/t/t-l-wojdx-jykykhhuld-i/)

December 18, 2025 11:20 AM EST
Updated 01:29 PM
In Focus
The EndÂ­points winÂ­ners and losers list: Who was up and who was down in 2025
ENDPOINTS
What a year! The XBI is up, M&A is bumpÂ­ing and the
vibes are imÂ­provÂ­ing
. But it ainâ€™t all ChristÂ­mas cookÂ­ies. As â€¦
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER

---

### [Neurocrineâ€™s Ingrezza flunks pivotal study in dyskinetic cerebral palsy](https://e.endpointsnews.com/t/t-l-wojdx-jykykhhuld-d/)

December 23, 2025 08:28 AM EST
R&D
NeuÂ­roÂ­crineâ€™s InÂ­grezÂ­za flunks pivÂ­otal study in dysÂ­kÂ­iÂ­netÂ­ic cereÂ­bral palÂ­sy
Ayisha Sharma
News Reporter
NeuÂ­roÂ­crine BioÂ­sciencesâ€™ InÂ­grezÂ­za has failed a late-stage triÂ­al in a type of cereÂ­bral palÂ­sy, adding to a spate of clinÂ­iÂ­cal disÂ­apÂ­pointÂ­ments for the biotech in â€¦
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER

---

### [Gilead's herpes deal; FDA approvals for Boehringer, Roche](https://e.endpointsnews.com/t/t-l-wojdx-jykykhhuld-h/)

December 23, 2025 09:46 AM EST
News Briefing
GileadÂ­'s herÂ­pes deal; FDA apÂ­provals for Boehringer, Roche
ENDPOINTS
Plus, news about BioÂ­Marin and CasÂ­saÂ­va.
ðŸ’Š
Gilead opts inÂ­to AsÂ­semÂ­bly Bioâ€™s genÂ­iÂ­tal herÂ­pes proÂ­grams:
As a reÂ­sult, Gilead will pay AsÂ­semÂ­bly $35 milÂ­lion based â€¦
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER

---

### [Updated: Pfizer discloses patient death in Hympavzi hemophilia trial](https://e.endpointsnews.com/t/t-l-wojdx-jykykhhuld-k/)

December 23, 2025 07:00 AM EST
Updated 08:07 AM
R&D
UpÂ­datÂ­ed: PfizÂ­er disÂ­closÂ­es paÂ­tient death in HymÂ­paÂ­vzi heÂ­moÂ­philÂ­ia triÂ­al
Elizabeth Cairns
Senior biopharma journalist
A paÂ­tient in PfizÂ­erâ€™s triÂ­al of its heÂ­moÂ­philÂ­ia drug HymÂ­paÂ­vzi died from a thromÂ­botÂ­ic stroke, the drugÂ­makÂ­er said MonÂ­day.
PfizÂ­er said it had inÂ­formed regÂ­uÂ­laÂ­tors â€¦
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP
LOG IN
BECOME A PREMIUM SUBSCRIBER

---

#daily-digest #healthcare-news
